Classifying Oropharyngeal Cancer by p16 Status Alone Deemed Insufficient
Oropharyngeal cancer patients who have discordant p16 and HPV status have worse prognosis than patients who have p16+/HPV+ disease, a study suggests.
Diagnosis & Disease Information
HPV-Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity
Non-Hispanic White men are less likely to die from HPV-related oropharyngeal cancer, when compared with Hispanic and non-Hispanic Black men.
De-Escalation Strategy Produces ‘Favorable’ Outcomes in Oropharyngeal Carcinoma
Reducing the radiotherapy dose and target volume to subclinical regions produced “favorable clinical outcomes,” according to researchers.
Oropharyngeal Cancer Incidence, Mortality Up Among U.S. Men
The incidence of oropharyngeal cancer in men increased 2.7% per year.
Incidence of Oropharyngeal Cancer Projected to Rise in U.S. Men
Under a status quo scenario based on current levels of HPV vaccination, 792,000 OPC cases in men would be prevented by the year 2100.
Surgery Plus Radiotherapy Yields ‘Outstanding’ PFS in HPV+ Oropharyngeal Cancer
The 2-year progression-free survival rate exceeded 90% for all treatment arms.
African-American Patients Have Worse Outcomes of Oropharyngeal Cancer Regardless of Access to Medical Care
Findings suggest a need for tailored treatment in oropharyngeal squamous cell carcinoma.
Study Establishes Feasibility of Reduced-Dose IMRT Plus Cisplatin in Good-Risk HPV-Associated OPSCC
Investigators tested the efficacy of reduced-dose radiation plus cisplatin in patients with good-risk human papillomavirus–associated oropharyngeal squamous cell carcinoma (OPSCC).
Factors Identified for Poor Long-Term Survival in RT-Treated Patients With Oropharyngeal Cancer
This analysis identified the factors for poor long-term survival in radiotherapy (RT)-treated patients with oropharyngeal cancer (OPC).
Transoral Robotic Surgery Ups Survival in Oropharyngeal Cancer
Outcomes and survival improved for early-stage oropharyngeal cancer, but not other cancers.
- Loading...
Loading...
Next post in Head and Neck Cancer
Loading... 
Loading...